Dizzy Dean for FDA Commissioner

  • by: |
  • 07/03/2006

Lots of polls and pols are reminding us almost daily that confidence in the FDA is on the decline. How much of this is caused by posturing and putting politics in front of the public health? A lot. But the numbers don’t lie.

So what can the FDA do to regain the confidence of the American public? I think that a large part of the answer is to tell the truth — that the agency is the world’s gold standard — and they’ve got the proof to back up that statement. As a mentor of mine once opined, “He that tooteth not his own horn, that horn shall go untooted.”

As Dizzy Dean said, “It ain’t bragging if you can do it.”

Just doing the right thing, day after day isn’t enough. Just addressing some of the most difficult and important regulatory issues of the day isn’t enough. Just working likes dogs for government pay isn’t enough. FDA must go on the offensive, knocking down untruths, mistruths, and half-truths one-by-one everytime they are floated in the media, in press releases, in public statements by grandstanding public officials, by vendetta-driven “whistle blowers.”

All of the research that I’ve seen makes it clear that the pubic wants to have faith in the FDA. They are willing to believe the FDA. But the FDA must go out and get it. Mix it up. Engage in the debate. The FDA has the bona fides while those basking in the Splendor in the Grassley are but paper tigers.

And the time is now. With the pending release of the Enzi/Kennedy bill and PDUFA reauthorization, now is the time to set the agency on an aggressive, accelerated Campaign of Confidence.

What better way to commence the FDA’s second hundred years.


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog